- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Hong Kong Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
2
0 new
High return on equity, past performance and sound balance sheet.
2 companies
Consun Pharmaceutical Group
Market Cap: HK$7.9b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$9.46
7D
-1.8%
1Y
68.9%
Uni-Bio Science Group
Market Cap: HK$406.0m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.068
7D
-1.4%
1Y
-18.1%